Welcome from the Chief
Infectious diseases have been major public health threats throughout history. Great strides have been made in the treatment and prevention of infectious diseases with antibiotics and vaccines however, new challenges continue to arise.
The URMC Infectious Diseases Division offers expertise in a wide range of areas including viral diseases such as Human Immunodeficiency Virus (HIV), Influenza, Respiratory Syncytial Virus (RSV) and Human Papilloma Virus (HPV) as well as bacterial infections including Methicillin Resistant Staphylococcus aureus, pneumococcus and Clostridium difficile and immunology. Our team has expertise in the care of transplant related infections, complex cardiac infections, infections in long term care facilities, sexually transmitted diseases and B cell immunology. Our division includes faculty at Highland, Rochester General and Unity Hospitals and maintains active clinical, research and educational missions.
Paul R. Bohjanen, MD, PhD
Chief, Infectious Diseases Division
Co-director, Translational Immunology and Infectious Diseases Institute
Division News
From the Newsroom
November 7, 2025
Spreading Knowledge, Not Disease at IDWeek 2025
March 14, 2025
URMC Joins National Network for Bronchiectasis and NTM Care
November 6, 2024
Three Ways You Can 'Check Your Health' with WDKX, University of Rochester
Why Are My Spring Allergies So Bad?
Can Cold Weather Make You Sick? Common Cold Myths Debunked
Does Strep Throat Go Away on Its Own?
Our Research Centers
Prevention Centers and Initiatives

Spotlight: Making RSV A Thing of the Past
Thanks to groundbreaking research, including decades of work at University of Rochester Medicine, we’re closer than ever to making respiratory syncytial virus (RSV) a thing of the past for infants and young children. In this commentary, Infectious Diseases physician-scientist Brenda Tesini, MD, likens RSV to Haemophilus influenza type B (HiB), which once plagued pediatric wards but is now so rare that it's challenging for residents to gain experience treating it. "That’s my hope for RSV—that physicians in training today will speak of it only as a thing of the past," she wrote.